Clinical Trial Update: Rasburicase for Treatment of Hyperuricemia in Children and Adolescence Patients With Tumor Lysis Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating rasburicase for treatment of hyperuricemia in children and adolescents with tumor lysis syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperuricemia
• Tumor Lysis Syndrome

Drugs mentioned

• Rasburicase (rasburicase)

Snippet

Sponsor: Sanofi | Conditions: Hyperuricemia | Phase 4 | Status: COMPLETED